The efficiency of the Pulmicort-Turbuhaler drug use during therapy in patients with bronchial asthma
Abstract
50 patients with various forms of bronchial asthma with moderate severity were investigated. The efficiency of Pulmicort—turbuhaler (PT) was evaluated in the patients by means ofthe clinical state dynamics, of the respiration function, of estimation of the need of aerosol simathomimetics and glucocorticoids in tablets. The treatment period was one month. The results showed the high efficacy of PT in bronchial asthma patients treatment. The severity and the frequency of asthma attacks and the need of sympathomimetics and glucocorticoids were decreased. After treatment with PT, the FEV1 increase was 18%. The expiratory flow increased by 20%, 17%, and 15% at MEF75, MEF50, and MEF25 levels respectively. During the aprobation of PT, there was satisfactory patience of the drug without side effects at the therapeutic dosage in 400—800 mkg/day.
References
1. Линдруус X. Применение высоких доз кортикостероидов в виде ингаляций при лечении астмы / / Пульмонология.— 1991.— No 2.— С.38—40.
2. Палеев Н.Р. / / Болезни органов дыхания: Руководство для врачей. Т.З. Частная пульмонология.— М.: Медицина, 1990.— С.5—102.
3. Bjorkander Tonigren Н., Johansson S.A. et al. Methodological aspects of clinical trials with inhaled corticosteroids: results of two comparisons between two steroid aerosols in patients with asthma / / Eur. J. Respir. Dis.— 1982.— Vol.63, Suppl.122.— P.108.
4. Clark T.J.H. Safety of inhaled corticosteroids / / Ibid.— P. 235—242.
5. Clarke P .S. The effect of beclomethasone dipropionate on bronchial hyperreactivity / / J.Asthma.— 1982.— Vol. 19.— P .91—93.
6. Harris D M . Properties and therapeutic uses of some corticosteroids with enhanced topical potency / / J. Steroid. Biochem.— 1975.— Vol.6.— P.711.
7. Harris D M . Clinical pharmacology of beclomethasone dipropionate / / Topical Steroid Treatment for Asthma and Rhinitis / Eds N.Mygind, T.J.H.Clark.— London: Bailliere Tindall, 1980.— P. 34.
8. Johansson S.A., Andersson K.E., Brattsand R. et al. Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man / / Eur. J. Clin. Pharmacol.— 1982.— Vol.22.— P.523.
9. Johansson S.A., Andersson K.E., Brattsand R. Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man / / Eur. J. Respir. Dis.— 1982.— Vol.63, Suppl.122.— P.74.
10. Konig P. Inhaled corticosteroids-their present and future role in the management of asthma / / J. Allergy Clin. Immunol.— 1988.— Vol.82.— P.297—306.
11. Ryrfildt A., Andersson P., Edsbacker S. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid / / Eur. J. Respir. Dis.— 1982.— Vol.63, Suppl.122.— P. 86.
12. Siegel S.C. Corticosteroid agents: overview of corticosteroid therapy / / J. Allergy Clin. Immunol.— 1985.— Vol.76.— P .312— 320.
13. Toogood J.H. High-dose inhaled steroid therapy for asthma / / Ibid.— 1989.— Vol.83.— P.528.
14. Vermeire P.A., Wittesaele W.M., Janssens E. et al. European audit of asthma therapy / / Chest.— 1986.— Vol.90, Suppl.l.— P.58—61.
Review
For citations:
Molostova T.N. The efficiency of the Pulmicort-Turbuhaler drug use during therapy in patients with bronchial asthma. PULMONOLOGIYA. 1994;(2):32-38. (In Russ.)
Views:
280
Email this article 